Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 14(11)2021 Nov 17.
Article in English | MEDLINE | ID: mdl-34789532

ABSTRACT

A 75-year-old man presented with a 3-week history of melaena and right upper quadrant pain. This was on a background of significant alcohol intake and a complex medical history. He was haemodynamically unstable with investigations indicating a new iron-deficiency anaemia. After resuscitation, urgent intervention was required under general anaesthesia. This involved a triple phase abdominal CT, followed by emergency oesophagogastroduodenoscopy. This revealed deep ulceration with extension to the pancreatic head and common bile duct. There was also evidence of pneumobilia on CT, secondary to a choledochoduodenal fistula. Treatment encompassed an invasive and medical approach. Following treatment, the patient was stable, with follow-up endoscopy exhibiting good duodenal mucosal healing.


Subject(s)
Biliary Fistula , Common Bile Duct Diseases , Duodenal Diseases , Duodenal Ulcer , Intestinal Fistula , Aged , Biliary Fistula/complications , Biliary Fistula/diagnostic imaging , Duodenal Diseases/complications , Duodenal Diseases/diagnostic imaging , Duodenal Ulcer/complications , Humans , Intestinal Fistula/complications , Intestinal Fistula/diagnostic imaging , Male
2.
Stroke Vasc Neurol ; 5(4): 315-322, 2020 12.
Article in English | MEDLINE | ID: mdl-33208493

ABSTRACT

BACKGROUND: Cerebral microhaemorrhages are increasingly being recognised as a complication of COVID-19. This observational retrospective study aims to further investigate the potential pathophysiology through assessing the pattern of microhaemorrhage and clinical characteristics of patients with COVID-19 and microhaemorrhage. By comparing with similar patterns of microhaemorrhage in other non-COVID-19 disease, this study aims to propose possible common pathogenic mechanisms. METHODS: A retrospective observational case series was performed identifying all patients with COVID-19 complicated by cerebral microhaemorrhage on MRI. The distribution and number of microhaemorrhages were recorded using the microbleed anatomical scale, and patients' baseline characteristics and salient test results were also recorded. RESULTS: Cerebral microhaemorrhages were noted to have a predilection for the corpus callosum, the juxtacortical white matter and brainstem. All patients had a preceding period of critical illness with respiratory failure and severe hypoxia necessitating intubation and mechanical ventilation. DISCUSSION: This study demonstrates a pattern of cerebral microhaemorrhage that is similar to the pattern reported in patients with non-COVID-19 related critical illness and other causes of severe hypoxia. This raises questions regarding whether microhaemorrhage occurs from endothelial dysfunction due the direct effect of SARS-CoV-2 infection or from the secondary effects of critical illness and hypoxia.


Subject(s)
COVID-19/complications , Cerebral Hemorrhage/etiology , Aged , Brain Stem/diagnostic imaging , COVID-19/diagnostic imaging , Cerebral Hemorrhage/diagnostic imaging , Corpus Callosum/diagnostic imaging , Critical Illness , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Respiration, Artificial , Respiratory Insufficiency/etiology , Retrospective Studies , Treatment Outcome , White Matter/diagnostic imaging
3.
Br J Radiol ; 92(1098): 20190078, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31039325

ABSTRACT

Autosomal dominant polycystic kidney disease (ADPKD) is the most common renal genetic disorder and a leading cause of end stage renal failure (ESRF) affecting over 12 million people worldwide. Whilst the mainstay of diagnosis has historically favoured the imaging domain, the progression of disease was until very recently thought to be best monitored via biochemical analysis, i.e. measurement of estimated glomerular filtration rate. Imaging modalities such as sonography, CT and MRI have more recently proven to be key in monitoring disease progression. As much as half of the renal parenchyma can be lost with no real derangement in renal function. Tolvaptan, a vasopressin antagonist has been shown to slow disease progression and preserve renal function. Here we discuss at length the pathogenesis of ADPKD, the various diagnostic challenges surrounding its evaluation, new treatment options and monitoring of disease progression via serial imaging. We also propose monitoring of the efficacy of Tolvaptan at slowing the rate of deterioration in renal function in patients with ADPKD through MRI guided volumetric analysis of the kidneys.


Subject(s)
Polycystic Kidney, Autosomal Dominant/drug therapy , Antidiuretic Hormone Receptor Antagonists/therapeutic use , Carcinoma, Renal Cell/etiology , Cysts/etiology , Diagnosis, Differential , Diagnostic Imaging , Disease Progression , Humans , Kidney Calculi/etiology , Kidney Neoplasms/etiology , Polycystic Kidney, Autosomal Dominant/diagnosis , Polycystic Kidney, Autosomal Dominant/etiology , Tolvaptan/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...